Communiqués Rigel Pharmaceuticals, Inc.

Actions

RIGL

US7665597024

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 15/07/2024			Varia. 5j.	Varia. 1 janv.
10,59 ^USD	+6,11 %		+34,56 %	-26,97 %

25/06	Rigel Pharmaceuticals va procéder à un regroupement d'actions à raison de 1 pour 10	MT
25/06	Mise à jour sectorielle : Les actions du secteur de la santé progressent avant la cloche mardi	MT

Communiqués

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Rigel Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)	12/07	PR
Rigel Announces Reverse Stock Split	25/06	PR
Rigel Announces Five Presentations at the EHA2024 Hybrid Congress	17/06	AQ
Rigel to Present at the Jefferies Global Healthcare Conference	30/05	PR
Rigel: Q1 Earnings Snapshot	07/05	AQ
Rigel Announces Conference Call and Webcast to Report First Quarter 2024 Financial Results and Business Update	30/04	PR
Rigel Pharmaceuticals : March 2024	16/04	PU
Rigel Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)	10/04	PR
Rigel Announces Publication of Data on REZLIDHIA in Post-Venetoclax Patients with Mutant IDH1 AML in Leukemia and Lymphoma	05/04	AQ
Rigel Pharmaceuticals Announces Appointment of Lisa Rojkjaer, M.D. as Chief Medical Officer	12/03	PR
Recent Market Movers: Healthcare Companies Making Headlines: DYAI, RIGL, ARDX, VERO, MEDS	28/02	AQ
Rigel Announces Conference Call and Webcast to Report Fourth Quarter and Full Year 2023 Financial Results and Business Update	27/02	PR
Rigel Pharmaceuticals Provides Business Update	09/01	AQ
Rigel Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)	05/01	PR
Rigel Announces Collaboration with CONNECT to Conduct a Phase 2 Trial of Olutasidenib in Glioma	04/01	PR
Rigel to Present at the 42nd Annual J.P. Morgan Healthcare Conference	03/01	PR
Rigel Pharmaceuticals and MD Anderson Announce Strategic Alliance to Advance REZLIDHIA in AML and Other Cancers	11/12	AQ
Rigel: Q3 Earnings Snapshot	07/11	AQ
Rigel to Present at the Jefferies London Healthcare Conference	06/11	PR
Rigel Announces Poster Presentations at the 65th American Society of Hematology Annual Meeting and Exposition	03/11	AQ

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués Rigel Pharmaceuticals, Inc.

Actions

RIGL

US7665597024

Communiqués

Filtres